You are here: Industry Insights > AstraZeneca

News List

Lynparza ASCO success continues with positive ovarian cancer results pharmatimes
June 05, 2019
AstraZeneca and MSD have shared positive results for Lynparza (olaparib) in previously treated germline BRCA1/2-mutated (gBRCAm) advanced ovarian cancer.
‘Unprecedented’ results in AZ’ late-stage Lynparza trial pharmatimes
June 03, 2019
Pancreatic cancer is the 12th most common cancer worldwide, with 458,918 new cases in 2018 alone.
AZ’ HER2 drug hits mid-stage trial endpoints pharmatimes
May 28, 2019
AstraZeneca’s HER2-targeting antibody drug conjugate (ADC), DS-8201 (trastuzumab deruxtecan), demonstrated a clinically meaningful response in patients with refractory HER2-positive metastatic breast cancer.
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits fiercepharma
May 21, 2019
AstraZeneca’s Fasenra has been stealing share from GlaxoSmithKline’s Nucala in severe asthma, and competition is even fiercer with Sanofi’s Dupixent approval.
AZ Symbicort reduces rate of asthma attacks pharmatimes
May 20, 2019
AstraZeneca’s Novel START trial for its Symbicort Turbuhaler (budesonide/formoterol) demonstrated a reduction in the rate of asthma attacks in patients with mild asthma, compared to common therapies.
Pooled Analyses of the Roxadustat Global Phase III Programme Confirmed Cardiovascular Safety drugs
May 20, 2019
Pooled Analyses of the Roxadustat Global Phase III Programme Confirmed Cardiovascular Safety.
AstraZeneca and Daiichi's HER2 ADC hits goal in pivotal trial fiercepharma
May 12, 2019
AstraZeneca and Daiichi Sankyo’s HER2-targeting antibody drug conjugate (ADC) has hit the primary endpoint in a pivotal phase 2 trial, teeing the partners up to file for FDA approval in the first half of the fiscal year.
AZ, Transgene to collaborate on immunotherapies pharmatimes
May 10, 2019
AZ, Transgene to collaborate on immunotherapies
AstraZeneca tees up PGA champ Day to push biomarker testing in lung cancer fiercepharma
May 09, 2019
AstraZeneca and pro golfer Jason Day are on a mission to encourage biomarker testing for lung cancer. For Day, the awareness campaign is personal—he found out two years ago that his mother had stage IV lung cancer.
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response biospectrumasia
May 09, 2019
Pivotal phase 2 DESTINY-Breast01 trial met primary endpoint, supporting global regulatory submission plan to start in first half of fiscal year 2019

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page